MTI-GlobalStem Announces Updated Company Identity and Website
Complete the form below to unlock access to ALL audio articles.
MTI-GlobalStem has announced the launch of an updated corporate identity, including new company name, logo and website. GlobalStem was formed in 2006 and acquired by Molecular Transfer, Inc. (MTI) in 2009. The company moved into a new, joint facility in 2014 to bring the two divisions closer together.
The formation of MTI-GlobalStem merged MTI’s technologies in the areas of transfection, transformation and gene delivery, with GlobalStem’s products and expertise in stem cell and neurobiology. The new corporate identity, which includes rebranding as MTI-GlobalStem, a new corporate logo, and a redesigned website, reflects the complete merger of the companies into a cohesive customer experience.
Dan Komarek, President and COO of MTI-GlobalStem, emphasized that “The rebranding and website will improve the customer experience by combining our two website into one, bring together the portfolio of products.”
The website redesign is an integral component of the company rebranding. The website features a clean, modern design; easy-to-navigate functionality to quickly find content; and improved access to product- and application-specific information to assist customers with their experiments. The website includes an optimized e-commerce function for a better online shopping experience, and the latest news and information on products for transfection, stem cell and neurobiology research.
Dan Komarek pointed out that the merged company has already launched a number of next-generation gene delivery transfection reagents, with more development to come. “This completes the merger of our two divisions, started in early 2014 with our new facility, that brought together our team of experts in chemistry, neurobiology, stem cell biology and cell culture development. This allowed us to develop and launch the next generation of gene delivery tools more quickly, and utilizes these tools for the development of new iPSC reprogrammed stem cells and stem cell-derived neural cells,” said Dan Komarek.
